Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide
Open Access
- 1 November 2016
- journal article
- Published by Elsevier BV
- Vol. 291 (45), 23545-23556
- https://doi.org/10.1074/jbc.m116.742460
Abstract
No abstract availableKeywords
Funding Information
- Bose Institute (Institutional Plan Project-II)
This publication has 65 references indexed in Scilit:
- Insulin-derived amyloidosisIndian Journal of Endocrinology and Metabolism, 2015
- Insulin-derived Amyloidosis and Poor Glycemic Control: A Case SeriesAmerican Journal Of Medicine, 2014
- Intrinsic Fibrillation of Fast-Acting Insulin AnalogsJournal of Diabetes Science and Technology, 2012
- The Amyloid State of Proteins in Human DiseasesCell, 2012
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothesNature Neuroscience, 2012
- Polymorphism in the intermediates and products of amyloid assemblyCurrent Opinion in Structural Biology, 2007
- Technical risks with subcutaneous insulin infusionDiabetes & Metabolism, 2006
- The structural basis of protein folding and its links with human diseasePhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- Interactions of Phenol and m-Cresol in the Insulin Hexamer, and Their Effect on the Association Properties of B28 Pro → Asp Insulin AnaloguesBiochemistry, 1998
- Mechanisms of Stabilization of the Insulin Hexamer through Allosteric Ligand InteractionsBiochemistry, 1997